ArticleInternational journal of chronic obstructive pulmonary disease

Cost-effectiveness of twice-daily indacaterol/glycopyrrolate inhalation powder for the treatment of moderate to severe COPD in the US.

Krithika Rajagopalan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.